IM6360-1mg MLi-2 is an orally active, highly selective LRRK2 inhibitor with potential for use in Parkinson's disease research. SKU: SLB-IM6360-1mg Supplier: Solarbio Unit: bottle Add to cart Contact Us Add to wishlist Price 147.41 € 147.41 € Terms and Conditions
